The journey of OBS Pharma (Pvt.) Ltd began in 2023, when OBS Group acquired Bayer AG’s manufacturing facility in Lahore, along with a distinguished portfolio of 11 established pharmaceutical brands. These include market leaders such as Travocort, Advantan, Skinoren, Nerisone, Travogen, Ciproxin, Noctamid, Proviron, Testoviron, Gravibinan, and Primolut-N—trusted by healthcare professionals and patients alike. Building on this strong foundation, OBS Pharma has rapidly expanded its footprint with new launches across Consumer HealthCare, Specialty HealthCare, and Women’s HealthCare—broadening access to high-quality, innovative treatment solutions. Proudly carrying forward a 60-year legacy of excellence while serving millions of patients annually, OBS Pharma has established a strong and independent identity rooted in quality, integrity, and innovation. Backed by a state-of-the-art, cGMP-compliant manufacturing facility and a team of dynamic professionals, we are committed to delivering top-tier pharmaceutical products with uncompromising quality and proven efficacy. At OBS Pharma, we don’t just manufacture medicines—we advance healthcare with purpose.